DLA Piper has advised Lasker Cross-Media on the entrance of three unidentified new investors.
It has been over a year since the European Union’s General Data Protection Regulation became mandatory across Europe, marking a seismic shift in the way that companies collect, process, and handle personal data. Countries across the European Union and beyond have adapted their national laws to meet the requirements of the GDPR – with many introducing local derogations as permitted by the GDPR.
Earlier this year, CEE Legal Matters reported that Herbst Kinsky Rechtsanwalte had advised Marinomed Biotech AG on its February 1, 2019 debut on the Vienna Stock Exchance, with Weber & Co. advising Erste Group Bank AG (as sole global coordinator) and Goetzpartners Securities Ltd (as co-lead manager) on the IPO. Marinomed’s was the first successful IPO in Austria since BAWAG’s in 2017.
Emmanuel Kaufman has a unique profile: An Argentinian lawyer and commercial and international investment arbitration specialist who has spent the last 12 years in two of the leading law firms in Austria. He has spent the last three and a half years as a partner at Knoetzl, where he focuses on complex arbitration proceedings in the construction, telecommunications, IT, gaming, and soft-beverages industries.
Under Austrian law, incorrect land register entries may trigger public liability. But the Austrian Supreme Court recently held that such incorrect entries only create public liability claims for of a certain group of people, thereby potentially increasing the risk management costs of mortgage-backed loans.
18-19 September, 2019, Vienna
The Supreme Court of Cassation in Italy has recently rendered a decision that products containing Cannabidiol (CBD) shall be prohibited from being marketed on the Italian market, even if they contain less than 0.2% of the psychoactive substance Tetrahydrocannabinol (THC). The sale of such products had previously been permitted based on an amendment to the law regulating hemp production that removed the requirement to obtain a permit for “cannabis light.” This led to a “cannabis light boom.” The change was triggered based on the opinion of the Highest Italian Sanitary Council that even such “cannabis light” products could conceivably endanger human health. Following the Supreme Court of Cassation’s ruling, only products specified as medicinal products or certain agricultural varieties may be sold.